Preticks
.
Follow Us
News Details
Basilea reports acceptance for regulatory review of Pfizer’s marketing authorization application for antifungal isavuconazole (Cresemba®) in China
About Pfizer, Inc.
NYSE: $PFE
Notified: $38.20
01:15 EDT
Price Chart